The consensus among 11 Wall Street analysts covering (NYSE: BMY) stock is to Buy BMY stock.
Is BMY worth buying?
Valuation metrics show that Bristol Myers Squibb Company may be undervalued. Its Value Score of A indicates it would be a good pick for value investors. The financial health and growth prospects of BMY, demonstrate its potential to outperform the market. It currently has a Growth Score of B.
Will BMY stock go up?
Stock Price Forecast
The 17 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 83.00, with a high estimate of 90.00 and a low estimate of 60.00. The median estimate represents a +9.33% increase from the last price of 75.92.
What is the target price for BMY stock?
Stock Price Target
| High | $90.00 |
|---|---|
| Low | $60.00 |
| Average | $80.46 |
| Current Price | $79.38 |
Why did BMY stock go down?
Milvexian is an important drug in the company’s mid-stage pipeline with a multi-billion dollar potential peak sales opportunity. As such, the development did not sit well with the investors, sending BMY’s stock price lower. BMS is focused on its expanding its pipeline to combat biosimilar competition.
Why invest in Bristol Myers?
Bristol-Myers has multiple top-selling drugs in its portfolio that generate billions in revenue. The company is a money-making machine that could bring in $50 billion in free cash over the next few years. Its low valuation and high dividend yield make it an all-around safe stock to just buy and hold.
What company is Bristol Myers buying?
“The acquisition of Turning Point Therapeutics further broadens our leading oncology franchise by adding a best-in-class, late-stage precision oncology asset,” said Giovanni Caforio, M.D., Board Chair and Chief Executive Officer, Bristol Myers Squibb.
How often does BMY pay a dividend?
4 dividends per year
There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 1.4.
When did Bristol Myers stock split?
Stock Split History
| Split Date | Rate |
|---|---|
| April 28, 1977 | 2 for 1 |
| April 28, 1983 | 2 for 1 |
| June 9, 1987 (Issue Date) May 12, 1987 (Record Date) | 2 for 1 |
| February 28, 1997 (Issue Date) February 7, 1997 (Record Date) | 2 for 1 |
What months does BMY pay dividends?
Bristol Myers’s next quarterly payment date is on Oct 31, 2022, when Bristol Myers shareholders who owned BMY shares before Oct 05, 2022 received a dividend payment of $0.54 per share. Add BMY to your watchlist to be reminded of BMY’s next dividend payment.
How much debt is BMY?
Bristol Myers Squibb long term debt for 2020 was $48.336B, a 11.41% increase from 2019. Bristol Myers Squibb long term debt for 2019 was $43.387B, a 668.46% increase from 2018.
Compare BMY With Other Stocks.
| Bristol Myers Squibb Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2009 | $6,130 |
Does Bristol Myers Squibb pay a dividend?
6, 2022.
What is BMY known for?
We are a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Bristol Myers Squibb is committed to patient care and is constantly working to shape the future of cancer care and improve the lives of cancer patients.
Does Buffett own Bristol Myers Squibb?
During that time, Berkshire snapped up shares in Merck, Pfizer, AbbVie and BMS that were valued at $5.66 billion at the time. The latest 13F shows that the company is no longer holding any of those stocks. Even Biogen found itself on Buffet’s radar, as Berkshire once owned a roughly $192 million stake.
Is Bristol Myers Squibb part of Pfizer?
About the Bristol-Myers Squibb/Pfizer Collaboration
This global alliance combines Bristol-Myers Squibb’s long-standing strengths in cardiovascular drug development and commercialization with Pfizer’s global scale and expertise in this field.
Who owns BMY stock?
The Vanguard Group, Inc.
Top 10 Owners of Bristol-Myers Squibb Co
| Stockholder | Stake | Shares owned |
|---|---|---|
| The Vanguard Group, Inc. | 8.84% | 187,936,711 |
| BlackRock Fund Advisors | 5.19% | 110,422,434 |
| SSgA Funds Management, Inc. | 4.37% | 92,928,369 |
| JPMorgan Investment Management, I… | 2.95% | 62,800,146 |
Is Bristol a good investment?
Rental Yields
Paired with the average rental yield of property in Bristol is 4.5% per annum (which is above the national average of 3.6%) there is a strong case to invest in property in Bristol.
Is Bristol-Myers Squibb dividend safe?
Is Bristol-Myers Squibb worth buying for its dividend? Earnings per share have been flat and Bristol-Myers Squibb’s dividend payouts are within reasonable limits; without a sharp decline in earnings we feel that the dividend is likely somewhat sustainable.
Is Bristol-Myers a good company?
Bristol-Myers Squibb is rated 4.8 out of 5, based on 41 reviews by employees on AmbitionBox. Bristol-Myers Squibb is known for Company culture which is rated at the top and given a rating of 4.5. However, Career growth is rated the lowest at 3.7 and can be improved.
What happened to Bristol-Myers contingent value rights?
Bristol Myers loses bid to toss $6.4B CVR lawsuit tied to Celgene takeover, Breyanzi approval. A U.S. federal court on Friday shot down Bristol Myers Squibb’s motion to dismiss an investor lawsuit connected to its $74 billion Celgene buyout.
Does Bristol-Myers pay well?
Bristol-Myers Squibb Company pays its employees an average of $103,756 a year. Salaries at Bristol-Myers Squibb Company range from an average of $66,453 to $163,490 a year.